Inogen Inc (INGN)
NASDAQ:INGN
Want to see INGN full AI Analyst Report?
INGN Stock Chart & Stats
$6.21
$0.43(4.59%)
At close: 4:00 PM EST
$6.21
$0.43(4.59%)
Day’s Range― - ―
52-Week Range$5.34 - $9.13
Previous CloseN/A
Volume110.44K
Average Volume (3M)245.06K
Market Cap
$191.82M
Enterprise Value$115.64M
Total Cash (Recent Filing)$110.17M
Total Debt (Recent Filing)$16.93M
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Aug 11, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding27,324,615
10 Day Avg. Volume350,876
30 Day Avg. Volume245,064
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.95
Price to Sales (P/S)0.52
P/FCF Ratio-8.46
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue0.33
Enterprise Value/Gross Profit0.69
Enterprise Value/Ebitda-10.54
Forecast
1Y Price Target
$12.00Price Target Upside93.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.78
Revenue Forecast (FY)$369.27M
Bulls Say, Bears Say
Bulls Say
New Medical Device LaunchesAnalyst points to upcoming launches of a stationary oxygen concentrator and a CPAP mask as potential drivers to expand product revenue and strengthen market competitiveness.
Revenue DiversificationAnalyst emphasizes diversification efforts designed to broaden revenue sources beyond existing offerings, lowering reliance on any single market and smoothing growth volatility.
Turnaround And ProfitabilityAnalyst highlights that the company's ongoing turnaround and improved adjusted operating profitability could stabilize cash flow and reduce pressure on margins, supporting investor confidence.
Bears Say
Commodity Exposure RiskAnalyst warns that exposure to oil-related markets creates earnings volatility risk if energy sector demand weakens or pricing shifts.
Guidance Shortfall And Demand SoftnessAnalyst notes that revenue guidance coming in below consensus and misses across US, international, and rental channels point to broader demand softness that could pressure near-term growth expectations.
Order Delays And Sales WeaknessAnalyst reports that order delays have depressed sales and hurt reported results, indicating execution challenges and potential short-term cash flow pressure.
Inogen News
INGN FAQ
What was Inogen Inc’s price range in the past 12 months?
Inogen Inc lowest stock price was $5.34 and its highest was $9.13 in the past 12 months.
What is Inogen Inc’s market cap?
Inogen Inc’s market cap is $191.82M.
When is Inogen Inc’s upcoming earnings report date?
Inogen Inc’s upcoming earnings report date is Aug 11, 2026 which is in 92 days.
How were Inogen Inc’s earnings last quarter?
Inogen Inc released its earnings results on May 07, 2026. The company reported -$0.3 earnings per share for the quarter, missing the consensus estimate of -$0.283 by -$0.017.
Is Inogen Inc overvalued?
According to Wall Street analysts Inogen Inc’s price is currently Undervalued.
Does Inogen Inc pay dividends?
Inogen Inc does not currently pay dividends.
What is Inogen Inc’s EPS estimate?
Inogen Inc’s EPS estimate is -0.17.
How many shares outstanding does Inogen Inc have?
Inogen Inc has 27,324,615 shares outstanding.
What happened to Inogen Inc’s price movement after its last earnings report?
Inogen Inc reported an EPS of -$0.3 in its last earnings report, missing expectations of -$0.283. Following the earnings report the stock price went down -2.364%.
Which hedge fund is a major shareholder of Inogen Inc?
Currently, no hedge funds are holding shares in INGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (93.24% Upside)
$12.00 (93.24% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 33.2K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-12.90%
Trailing 12-Months
Asset Growth
-7.29%
Trailing 12-Months
Company Description
Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
INGN Company Deck
INGN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflects a company in transition: solid top-line growth driven by international expansion, strong unit volume gains, new product launches with encouraging early clinical and commercial signals, and a healthy balance sheet. Offsetting these positives are meaningful near-term headwinds in the U.S. market (declining direct and rental sales), higher operating losses due to accelerated R&D and commercial investments, and reliance on a FX tailwind. Management reaffirmed full-year guidance and expects EBITDA improvement, but several financial metrics remain under pressure in the near term.View all INGN earnings summariesINGN Stock 12 Month Forecast
Average Price Target
$12.00
▲(93.24% Upside)
Technical Analysis
Ownership Overview
2.85% Insiders
17.24% Mutual Funds
1.87% Other Institutional Investors
69.06% Public Companies and
Individual Investors